Antiinfectives are also classified in the following groups:
A01AB Antiinfectives and antiseptics for local oral treatment
A02BD Combinations for eradication of Helicobacter pylori
A07A Intestinal antiinfectives
D01 Antifungals for dermatological use
D06 Antibiotics and chemotherapeutics for dermatological use
D07C Corticosteroids, combinations with antibiotics
D09AA Ointment dressings with antiinfectives
D10AF Antiinfectives for treatment of acne
G01 Gynecological antiinfectives and antiseptics
P Antiparasitic products, insecticides and repellents
R05X Other cold preparations
S03 Eye and ear preparations with antiinfectives
Even systemically administered antibacterials and antimycotics may be classified in other groups if their target is exclusively local, e.g. the skin - D01 - Antifungals for dermatological use
Inhaled antiinfectives are classified in J.
|The DDDs for the antiinfectives are as a main rule based on the use in infections of moderate severity. However, some antiinfectives are only used in severe infections and their DDDs are assigned accordingly. The DDDs assigned are based on daily treatment. The duration of the treatment periods is not taken into consideration. For antiinfectives given in a high initially starting dose followed by a lower daily "maintenance" dose, the DDDs are based on the "maintenance" dose if the total duration of the treat-ment course is more than one week. If, however, the treatment course is 7 days or less, the DDDs are assigned according to the average daily dose i.e. the total course dose divided by the number of treatment days (e.g azithromycin).|
The vaccines are divided in bacterial, viral and combinations of bacterial and viral at separate ATC 3rd levels. Subdivision at the 4th level is made mainly according to indication, while subdivision at the 5th level is mainly related to the manufacturing process. Combinations of vaccines within the same 3rd level are given separate 5th levels using the 50-series. 5th levels may contain adjuvans.
See comments under the 4th levels.
|No DDDs have been assigned.|
J07A BACTERIAL VACCINES
Combinations with typhoid vaccine are classified in this group.
J07AF Diphtheria vaccines
Different strengths of the diphtheria vaccines are classified at the same 5th level. Combinations with tetanus vaccine are classified in J07AM. Combinations with both tetanus and pertussis are classified in J07AJ.
Combinations with hemophilus influenza and tetanus vaccines are classified in J07AG.
Combinatins with poliomyelitis and/or rubella are classified in J07CA.
Combinations with diphtheria and tetanus vaccines are classified here.
Combinations with pertussis and toxoids are classified here.
Combinations with poliomyelitis are classified in J07CA.
J07AH Meningococcal vaccines
Meningococcal vaccines are classified at separate 5th levels according to the number of serotypes of neisseria meningitis contained in the vaccine. Monovalent vaccines obtained from group A are classified at a separate 5th level, while other monovalent vaccines are classified together.
Products containing oligosaccharides instead of polysaccharides may be included at each 5th level.
J07AJ Pertussis vaccines
Combinations with tetanus and/or diphtheria vaccine are classified in this group.
Combinations with hemophilus influenzae B are classified in J07AG.
Combinations with polimyelitis are classified in J07CA.
Combinations with tetanus immunoglobulin are classified in this group. Combinations with diphtheria and/or typhoid vaccines are classified in J07AM51.
Combinations with diphtheria and pertussis vaccines are classified in J07AJ.
Combinations with hemophilus influenza and diphteria vaccines are classified in J07AG.
Combinations with poliomyelitis and/or rubella are classified in J07CA.
Combinations with tetanus vaccine, also when including diphtheria vaccine, are classified in J07AM.
This group comprises bacterial vaccines, which cannot be classified in the preceding groups, e.g. Q fever vaccine.
Last updated: 2015-12-16